Brief ReportBrief Report
Severe Rhabdomyolysis and Acute Renal Failure Secondary to Concomitant Use of Simvastatin, Amiodarone, and Atazanavir
Ginelle A. Schmidt, James D. Hoehns, Jessica L. Purcell, Robert L. Friedman and Yasir Elhawi
The Journal of the American Board of Family
Medicine July 2007, 20 (4) 411-416; DOI: https://doi.org/10.3122/jabfm.2007.04.060187
Ginelle A. Schmidt
PharmD
James D. Hoehns
PharmD, BCPS
Jessica L. Purcell
PharmD, MPH
Robert L. Friedman
MD
References
- ↵Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–9.
- Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7–22.
- Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349–57.
- ↵Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation 2004; 109: 50–7.
- ↵Williams D, Freely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet 2002; 41: 343–70.
- ↵Pasternak RC, Smith SC Jr, Bairey-Merz CN, et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 2002; 40: 567–72.
- ↵Ricaurte B, Guirguis A, Taylor HC, Zabriskie D. Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity. Ann Pharmacother 2006; 40: 753–7.
- ↵Wratchford P, Ponte CD. High-dose simvastatin and rhabdomyolysis. Am J Health Syst Pharm 2003; 60: 698–700.
- Graham D, Staffa J, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 2004; 292: 2585–90.
- Jacobson T. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors. Am J Cardiology 2004; 94: 1140–46.
- ↵IMS Health. Press room. 2004 year-end U.S. prescription and sales information and commentary. IMS Health Incorporated; 2007 [cited 2005 February]. Available from: http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_3665_69890098,00.html.
- ↵Roten L, Schoenenberger RA, Krahenbuhl S, Schlienger R. Rhabdomyolysis in association with simvastatin and amiodarone. Ann Pharmacother 2004; 38: 978–81.
- ↵Grundy S. The issue of statin safety: Where do we stand? Circulation 2005; 111: 3016–19.
- ↵Zocor (simvastatin) package insert. Whitehouse Station (NJ): Merck & Co. Inc.; 2004.
- ↵
- ↵McKelvie PA, Dennett X. Myopathy associated with HMG-CoA reductase inhibitors (statins): A series of 10 patients and review of literature. J Clin Neuro Disease 2003; 3: 143–8.
- ↵Dresser G, Spence D, Bailey D. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokint 2000; 38: 41–57.
- ↵Lipitor (atorvastatin) prescribing information. Pfizer Inc.; 2005.
- ↵Ohyama K, Nakajima M, Suzuki M, Shimada N, Yamazaki H, Yokoi T. Inhibitory effects of amiodarone and its N-desethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions. Br J Clin Pharmacol 2000; 49: 244–53.
- ↵Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse reactions. Clin Pharmacol Ther 1981; 30: 239–45.
- ↵
- ↵Hsyu PH, Schultz-Smith MD, Lillibridge JH, Lewis RH, Kerr BM. Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin. Antimicrob Agents Chemother 2001; 4: 3445–50.
- ↵Sax PE. Strategies for management and treatment of dyslipidemia in HIV/AIDS. AIDS Care 2006; 18: 149–57.
- ↵Fichtenbaum C, Gerber J, Rosenkranz S, et al. Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047. AIDS 2002; 16: 569–77.
- ↵Reyataz (atazanavir sulfate) package insert. Bristol-Myers Squibb Company; 2006.
- ↵Hare CB, Vu MP, Grunfeld C, Lampiris HW. Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death. CID 35: e111–e112, 2002.
- ↵
- ↵Moro H, Tsukada H, Tanuma A, et al. Rhabdomyolysis after simvastatin therapy in an HIV-infected patient with chronic renal failure. AIDS Patient Care STDS 2004; 18: 687–90.
- ↵Cheng CH, Miller C, Lowe C, Pearson VE. Rhabdomyolysis due to probable interaction between simvastatin and ritonavir. Am J Health Syst Pharm 2002; 59: 728–30.
- Mah Ming JB, Gill MJ. Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV. AIDS Patient Care STDS 2003; 17: 207–10.
- ↵Castro JG, Gutierrez L. Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine. Am J Med 2002; 112: 505.
- Aboulafia DM, Johnston R. Simvastatin-induced rhabdomyolysis in an HIV-infected patient with coronary artery disease. AIDS Patient Care STDS 2000; 14: 13–8.
- ↵Martinez E, Tuset M, Milinkovic A, Miro JM, Gatell JM. Management of dyslipidemia in HIV-infected patients receiving antiretroviral therapy. Anitvir Ther 2004; 9: 649–63.
- ↵Barahona M, Mauri A, Sucunza N, Paredes R, Wagner AM. Hypothyroidism as a cause of rhabdomyolysis. Endocr J 2002; 49: 621–3.
- ↵Antons KA, Williams CD, Baker SK, Phillips PS. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 2006; 119: 400–9.
- ↵Pacerone (amiodarone) package insert. Upsher-Smith Laboratories, Inc.; 2004.
In this issue
The Journal of the American Board of Family
Medicine
Vol. 20, Issue 4
July-August 2007
Severe Rhabdomyolysis and Acute Renal Failure Secondary to Concomitant Use of Simvastatin, Amiodarone, and Atazanavir
Ginelle A. Schmidt, James D. Hoehns, Jessica L. Purcell, Robert L. Friedman, Yasir Elhawi
The Journal of the American Board of Family
Medicine Jul 2007, 20 (4) 411-416; DOI: 10.3122/jabfm.2007.04.060187
Severe Rhabdomyolysis and Acute Renal Failure Secondary to Concomitant Use of Simvastatin, Amiodarone, and Atazanavir
Ginelle A. Schmidt, James D. Hoehns, Jessica L. Purcell, Robert L. Friedman, Yasir Elhawi
The Journal of the American Board of Family
Medicine Jul 2007, 20 (4) 411-416; DOI: 10.3122/jabfm.2007.04.060187
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.